Showing results (111-120 of 167) with videos related to
Sort By:
Pageof 17
Transplantation Proceedings|May 22, 2021
Impact of Anesthesiologist Experience on Early Outcomes in Adult Orthotopic Liver TransplantationWilliam D Stoll, Robert A Mester, James N Fleming, et al.Transplantation|December 24, 2005
Does bioequivalence between modified cyclosporine formulations translate into equal outcomes?David J Taber, G Mark Baillie, Elizabeth E Ashcraft, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 23, 2002
Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipientsDavid J Taber, Robert E Dupuis, Amy L Fann, et al.Spine|October 7, 2022
Opioid Use Patterns in a Statewide Adult Medicaid Population Undergoing Elective Lumbar Spine SurgeryCharles A Reitman, Ralph Ward, David J Taber, et al.Hypertension (Dallas, Tex. : 1979)|July 13, 2016
Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant RecipientsDavid J Taber, Kelly J Hunt, Cory E Fominaya, et al.Clinical Transplantation|August 29, 2019
Protocol-based nurse coordinator management of ambulatory tacrolimus dosing in de novo renal transplant recipients-A single-center experience with a large African American populationZana Elmaasarani, Caitlin Mardis, Logan Gylten, et al.Journal of Cardiovascular Pharmacology and Therapeutics|December 22, 2012
The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplantDavid J Taber, Nicole A Pilch, Holly B Meadows, et al.Clinical Transplantation|September 3, 2013
Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithmKenneth D Chavin, David J Taber, Melissa Norcross, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 22, 2026
Single-Center, Open-Label, Randomized Controlled Trial Comparing the Tolerability of Maribavir 400mg Twice Daily versus Standard Dose Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant RecipientsDavid J Taber, Hannah Culpepper, Courtney E Harris, et al.Clinical Transplantation|February 26, 2016
A randomized, prospective comparison of transition to sirolimus-based CNI-minimization or withdrawal in African American kidney transplant recipientsJames N Fleming, David J Taber, Nicole A Pilch, et al.Pageof 17